Evidence map›Paper›PMID 27232721›Full record

ArticleJournal of biomedical optics2016

Optical clearing of skin enhanced with hyaluronic acid for increased contrast of optoacoustic imaging.

Anton Liopo, Richard Su, Dmitri A Tsyboulski, Alexander A Oraevsky

Abstract read
In one paragraph

Article in Journal of biomedical optics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Anton LiopoTomoWave Laboratories, 6550 Mapleridge Street Suite 124, Houston, Texas 77081, United States.
Richard SuTomoWave Laboratories, 6550 Mapleridge Street Suite 124, Houston, Texas 77081, United StatesbUniversity of Houston, Department of Biomedical Engineering, 3600 Calhoun Road, Houston, Texas 77004, United States.
Dmitri A TsyboulskiTomoWave Laboratories, 6550 Mapleridge Street Suite 124, Houston, Texas 77081, United States.
Alexander A OraevskyTomoWave Laboratories, 6550 Mapleridge Street Suite 124, Houston, Texas 77081, United StatesbUniversity of Houston, Department of Biomedical Engineering, 3600 Calhoun Road, Houston, Texas 77004, United States.

Funding

Multimode laser optoacoustic tomography system for breast cancer careR01CA167446 · NCI · TOMOWAVE LABORATORIES, INC. · PI ORAEVSKY, ALEXANDER A · 2012 to 2016
$2.5M
NCI NIH HHS R01 CA167446NCI NIH HHS R01CA167446
6 · The paper itself

Abstract

Enhanced delivery of optical clearing agents (OCA) through skin may improve sensitivity of optical and optoacoustic (OA) methods of imaging, sensing, and monitoring. This report describes a two-step method for enhancement of light penetration through skin. Here, we demonstrate that topical application of hyaluronic acid (HA) improves skin penetration of hydrophilic and lipophilic OCA and thus enhances their performance. We examined the OC effect of 100% polyethylene and polypropylene glycols (PPGs) and their mixture after pretreatment by HA, and demonstrated significant increase in efficiency of light penetration through skin. Increased light transmission resulted in a significant increase of OA image contrast in vitro. Topical pretreatment of skin for about 30 min with 0.5% HA in aqueous solution offers effective delivery of low molecular weight OCA such as a mixture of PPG-425 and polyethylene glycol (PEG)-400. The developed approach of pretreatment by HA prior to application of clearing agents (PEG and PPG) resulted in a ∼ 47-fold increase in transmission of red and near-infrared light and significantly enhanced contrast of OA images.

Indexed as

AnimalsContrast MediaHyaluronic AcidOptical ImagingPhotoacoustic TechniquesSkinSwineContrast MediaHyaluronic Acid

Identifiers

PMID27232721
PMCPMC4882400

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.